Clinical trial
Effects of Early Correction of Anemia in Patients With Chronic Renal…
NCT00312871 · Janssen Cilag S.A.S., Industry · Terminated
Key facts
| NCT number | NCT00312871 |
|---|---|
| Title | Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency |
| Official title | Effect of Early Correction of Anemia on the Progression of Chronic Renal Insufficiency (ECAP) |
| Lead sponsor | Janssen Cilag S.A.S., Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, Renal Failure, Chronic Renal Failure |
| Intervention type | Drug |
| Interventions | Epoetin alfa |
| Enrollment | 217 |
| Start date | Feb 1, 2001 |
| Completion | Jun 1, 2003 |
| First posted | Apr 11, 2006 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: